Ipratropium Bromide 0.5 mg and Albuterol Sulfate 3 mg Inhalation Solution, packaged in 30x3 mL Sterile Unit-Dose Vials, a) 30 count (NDC 0487-0201-03) and b) 60 count (NDC 0487-0201-60) vials per carton, Rx only, Nephron Pharmaceutical Corporation, Orlando, FL
Class I - DangerousWhat Should You Do?
- Check if you have this product: a) Lot D4E20A, exp 3/2016 and b) Lot D4C21A, exp 3/2016
- Do not eat it: Even if it looks and smells fine, do not consume this product.
- Throw it away or return it: You can return the product to the store for a full refund.
- Seek medical attention if needed: If you've consumed this product and feel unwell, contact your doctor immediately.
- Report problems: Report any issues to the FDA's Safety Reporting Portal.
⚠️ Emergency: If you experience severe symptoms after consuming this product, call 911 or Poison Control at 1-800-222-1222.
Recall Details
- Company:
- Nephron Pharmaceuticals Corp.
- Reason for Recall:
- Lack of Assurance of Sterility; potential exposure to non-sterile lubricant during the filling process
- Classification:
- Class I - Dangerous
Dangerous or defective products that predictably could cause serious health problems or death.
- Status:
- terminated
Product Information
Full Description:
Ipratropium Bromide 0.5 mg and Albuterol Sulfate 3 mg Inhalation Solution, packaged in 30x3 mL Sterile Unit-Dose Vials, a) 30 count (NDC 0487-0201-03) and b) 60 count (NDC 0487-0201-60) vials per carton, Rx only, Nephron Pharmaceutical Corporation, Orlando, FL
Product Codes/Lot Numbers:
a) Lot D4E20A, exp 3/2016 and b) Lot D4C21A, exp 3/2016
Official Source
Always verify recall information with the official FDA source:
View on FDA.govFDA Recall Number: D-0010-2016
Related Recalls
Lack of Assurance of Sterility: Internal dye ingress test failure to assure the integrity of the vial.
Lack of Assurance of Sterility: Internal dye ingress test failure to assure the integrity of the vial.
Discoloration